Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic

Patients with inflammatory diseases who receive moderate or high-risk anti-inflammatory therapies might be considered as an increased risk group for severe COVID-19 and appropriate measures should be taken in order to protect them. . Initiation of immuno-suppressive/modulatory therapies should be do...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mediterr J Rheumatol
Main Authors: Apostolou, Theofanis, Koutroubakis, Ioannis E., Manolakopoulos, Spilios, Mantzaris, Gerasimos, Rigopoulos, Dimitrios, Triantafyllou, Konstantinos, Vassilopoulos, Dimitrios
Format: Artigo
Jezik:Inglês
Izdano: The Mediterranean Journal of Rheumatology (MJR) 2020
Teme:
Joint Position Statement
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656124/
https://ncbi.nlm.nih.gov/pubmed/33196008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.3.295
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki